302 related articles for article (PubMed ID: 20740583)
1. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.
Liu X; Cheng Y; Sheng W; Lu H; Xu Y; Long Z; Zhu H; Wang Y
J Surg Oncol; 2010 Sep; 102(3):249-55. PubMed ID: 20740583
[TBL] [Abstract][Full Text] [Related]
2. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Liu X; Sheng W; Wang Y
J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
[TBL] [Abstract][Full Text] [Related]
3. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers.
Chang YC; Nagasue N; Abe S; Taniura H; Kumar DD; Nakamura T
Am J Gastroenterol; 1992 Mar; 87(3):321-5. PubMed ID: 1371637
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.
Kamei S; Kono K; Amemiya H; Takahashi A; Sugai H; Ichihara F; Fujii H; Matsumoto Y
J Gastroenterol; 2003; 38(6):540-7. PubMed ID: 12825129
[TBL] [Abstract][Full Text] [Related]
5. [The characters of AFP-producing early gastric cancer].
Chang YC; Nagasue N; Abe S; Kohno H; Yamanoi A; Uchida M; Nakamura T
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1574-80. PubMed ID: 1702182
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Kono K; Amemiya H; Sekikawa T; Iizuka H; Takahashi A; Fujii H; Matsumoto Y
Dig Surg; 2002; 19(5):359-65; discussion 365. PubMed ID: 12435906
[TBL] [Abstract][Full Text] [Related]
7. Roles of histological findings and serum AFP levels in the prognosis of AFP-producing gastric cancers.
Uefuji K; Ichikura T; Tamakuma S
Jpn J Clin Oncol; 1994 Jun; 24(3):135-40. PubMed ID: 7516444
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer.
Inoue M; Sano T; Kuchiba A; Taniguchi H; Fukagawa T; Katai H
Br J Surg; 2010 Jul; 97(7):1056-61. PubMed ID: 20632272
[TBL] [Abstract][Full Text] [Related]
9. Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis.
Koide N; Nishio A; Igarashi J; Kajikawa S; Adachi W; Amano J
Am J Gastroenterol; 1999 Jun; 94(6):1658-63. PubMed ID: 10364040
[TBL] [Abstract][Full Text] [Related]
10. Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.
Ishigami S; Natsugoe S; Nakashima H; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Nakashima S; Hokita S; Aikou T
Hepatogastroenterology; 2006; 53(69):338-41. PubMed ID: 16795967
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer.
Chang YC; Nagasue N; Kohno H; Taniura H; Uchida M; Yamanoi A; Kimoto T; Nakamura T
Am J Gastroenterol; 1990 Nov; 85(11):1480-5. PubMed ID: 1700600
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
[TBL] [Abstract][Full Text] [Related]
13. The potential for the development of liver metastasis from alpha-fetoprotein-producing human gastric carcinomas in nude mice.
Sawada H; Nakatani K; Watanabe A; Nishiwada T; Okumura T; Yamada Y; Yano T; Shino Y; Yamada T; Tanase M
Jpn J Clin Oncol; 1992 Oct; 22(5):303-7. PubMed ID: 1281894
[TBL] [Abstract][Full Text] [Related]
14. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
Gao YB; Zhang DF; Jin XL; Xiao JC
J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
[TBL] [Abstract][Full Text] [Related]
15. High level of serum AFP is an independent negative prognostic factor in gastric cancer.
Chen Y; Qu H; Jian M; Sun G; He Q
Int J Biol Markers; 2015 Nov; 30(4):e387-93. PubMed ID: 26349668
[TBL] [Abstract][Full Text] [Related]
16. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological study of AFP producing gastric cancer--significance of AFP in gastric cancer].
Takahashi Y; Mai M; Ogino T; Ueda H; Sawaguchi K; Ueno M
Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):696-700. PubMed ID: 2442592
[TBL] [Abstract][Full Text] [Related]
18. FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer.
Kochi M; Fujii M; Kaiga T; Takahashi T; Morishita Y; Kobayashi M; Kasakura Y; Takayama T
Oncology; 2004; 66(6):445-9. PubMed ID: 15452373
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
20. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
